JUN and acute myeloid leukemia: Based on the aforementioned studies and in consideration of the importance of the JNK/c-Jun/NF-κB signaling pathway in AML, a novel idea was proposed that Nrf2 may inhibit RFC4 expression by activating the JNK/C-Jun/p65 signaling pathway in AML.